Stella Pharma Corporation (TYO:4888)

Stella Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 29, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	13,035	13,035	9,087	11,485	17,281	-
Market Cap Growth	43.45%	43.45%	-20.88%	-33.54%	-	-
Enterprise Value	10,595	10,396	7,501	10,146	14,767	-
Last Close Price	383.00	383.00	291.00	387.00	603.00	-
PS Ratio	13.56	13.56	33.78	50.15	172.82	-
PB Ratio	4.06	4.07	3.82	4.17	5.61	-
P/TBV Ratio	4.13	4.13	3.91	4.27	5.74	-
P/FCF Ratio	95.85	95.85	-	-	-	-
P/OCF Ratio	93.11	93.11	-	-	-	-
EV/Sales Ratio	11.03	10.82	27.88	44.31	147.68	-
EV/FCF Ratio	77.90	76.44	-	-	-	-
Debt / Equity Ratio	0.24	0.24	0.39	0.40	0.41	6.14
Debt / FCF Ratio	5.63	5.63	-	-	-	-
Asset Turnover	0.21	0.21	0.07	0.05	0.03	0.09
Inventory Turnover	0.10	0.10	0.05	0.03	0.03	0.07
Quick Ratio	10.05	10.05	5.34	6.58	10.69	4.09
Current Ratio	13.44	13.44	7.98	9.01	13.56	5.67
Return on Equity (ROE)	-5.01%	-5.01%	-29.76%	-26.68%	-46.36%	-143.26%
Return on Assets (ROA)	-1.22%	-1.22%	-11.66%	-11.14%	-13.69%	-18.08%
Return on Capital (ROIC)	-1.54%	-1.54%	-13.28%	-12.32%	-15.50%	-21.79%
Earnings Yield	-1.07%	-1.07%	-8.40%	-6.77%	-4.44%	-
FCF Yield	1.04%	1.04%	-9.75%	-7.43%	-6.52%	-
Buyback Yield / Dilution	-7.76%	-7.76%	-7.27%	-2.83%	-40.17%	-28.43%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.